APA (7th ed.) Citation

Gulliver, W., Gooderham, M. J., Zhu, B., Jossart, C., Montmayeur, S., Burge, R., & Reed, C. (2023). Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program. Dermatology & Therapy, 13(1), 235. https://doi.org/10.1007/s13555-022-00853-4

Chicago Style (17th ed.) Citation

Gulliver, Wayne, Melinda J. Gooderham, Baojin Zhu, Christian Jossart, Sonia Montmayeur, Russel Burge, and Catherine Reed. "Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program." Dermatology & Therapy 13, no. 1 (2023): 235. https://doi.org/10.1007/s13555-022-00853-4.

MLA (9th ed.) Citation

Gulliver, Wayne, et al. "Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program." Dermatology & Therapy, vol. 13, no. 1, 2023, p. 235, https://doi.org/10.1007/s13555-022-00853-4.